Pomegranate fruit extract impairs invasion and motility in human breast cancer
*might not be compatible with chemo etc.
Pomegranate fruit extract impairs invasion and motility in human breast cancer Integrative Cancer Therapies , 10/12/09
Khan GN et al. – Inhibition of motility and invasion by PFEs, coincident with suppressed RhoC and RhoA protein expression, suggests a role for these defined extracts in lowering the metastatic potential of aggressive breast cancer species. Methods
|
Re: Pomegranate fruit extract impairs invasion and motility in human breast cancer
Pomegranate Fruit Extract Impairs Invasion and Motility in Human Breast Cancer
Gazala N. Khan Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA, gkhan@umich.edu Michael A. Gorin Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA Devin Rosenthal Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA Quintin Pan Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA Li Wei Bao Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA Zhi Fen Wu Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA Robert A. Newman Department of Experimental Therapeutics, M.D. Anderson Cancer Center, Houston,TX, USA, Punisyn Pharmaceuticals, Haifa, Israel Alison D. Pawlus Department of Experimental Therapeutics, M.D. Anderson Cancer Center, Houston,TX, USA Peiying Yang Department of Experimental Therapeutics, M.D. Anderson Cancer Center, Houston,TX, USA Ephraim P. Lansky Punisyn Pharmaceuticals, Haifa, Israel Sofia D. Merajver Department of Internal Medicine, University of Michigan,Ann Arbor, MI, USA Purpose. Pomegranate fruit extracts (PFEs) possess polyphenolic and other compounds with antiproliferative, pro-apoptotic and anti-inflammatory effects in prostate, lung, and other cancers. Because nuclear transcription factor-kB (NF-kB) is known to regulate cell survival, proliferation, tumorigenesis, and inflammation, it was postulated that PFEs may exert anticancer effects at least in part by modulating NF-kB activity. Experimental design. The authors investigated the effect of a novel, defined PFE consisting of both fermented juice and seed oil on the NF-kB pathway, which is constitutively active in aggressive breast cancer cell lines. The effects of the PFE on NF-kB—regulated cellular processes such as cell survival, proliferation, and invasion were also examined. Results. Analytical characterization of the bioactive components of the PFE revealed active constituents, mainly ellagitannins and phenolic acids in the aqueous PFE and conjugated octadecatrienoic acids in the lipid PFE derived from seeds.The aqueous PFE dose-dependently inhibited NF-kB—dependent reporter gene expression associated with proliferation, invasion, and motility in aggressive breast cancer phenotypes while decreasing RhoC and RhoA protein expression. Conclusion. Inhibition of motility and invasion by PFEs, coincident with suppressed RhoC and RhoA protein expression, suggests a role for these defined extracts in lowering the metastatic potential of aggressive breast cancer species. Key Words: breast cancer • cancer prevention • in vitro studies • Punica granatum Integrative Cancer Therapies, Vol. 8, No. 3, 242-253 (2009) DOI: 10.1177/1534735409341405 |
Re: Pomegranate fruit extract impairs invasion and motility in human breast cancer
Rich, thanks for posting. I find this early research to be very exciting and emphasizes the importance of variety in a healthy diet.
|
All times are GMT -7. The time now is 12:39 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021